| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |